Skip to main content

Table 1 Patient and Tumor Characteristics and Prior Treatment (N = 25)

From: Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

Characteristic or Treatment

No. of Patients

Zubrod performance status score

 

   0

22

   1

1

   2

2

Race

 

   White

22

   Hispanic

2

   Black

1

Primary tumor site

 

   Ovary

22

   Peritoneum

2

   Fallopian tube

1

Histologic subtype

 

   Serous

22

   Clear cell

1

   Endometrioid

1

   Adenocarcinoma

1

First-line chemotherapy

 

   Paclitaxel and carboplatin

23

   Paclitaxel and cisplatin

1

   Cisplatin and doxorubicin

1

Prior reinduction chemotherapy

 

   Carboplatin

4

   High dose with bone marrow transplantation

1

   None

20

Prior hormonal treatment

 

   Yes

10

   No

15

Pelvic irradiation

 

   Yes

1

   No

24